New system provides greater efficiency and flexibility in managing patient data and strengthens Phase IIb-IV offering KING OF PRUSSIA, PA, April 6 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has adopted DataLabs Clinical Electronic Data Capture (EDC) system for increased efficiency and flexibility in managing patient data from clinical trials in geographically diverse sites. "The adoption of this new system reflects our commitment to strengthen our Global Clinical Development line of business," said MDS Pharma Services President, Gilbert Godin. "This technology enhances our ability to meet growing client demand for our Phase IIb-IV clinical trial management services and sharpens MDS Pharma Service's competitive positioning in this fast growing market." The DataLabs Clinical electronic data management system unifies the functionality of paper data entry with the flexibility of EDC into one easy to use, web-based electronic data management platform. The system allows MDS Pharma Services to design a clinical study once, collect data either through paper data entry or EDC, and clean and manage the data with the same system, using virtually the same process. "DataLabs is pleased to add MDS Pharma Services to our Contract Research Organization (CRO) Partners Program," said DataLabs President, Jim Langford. "DataLabs has become the leading software company for the CRO industry by providing significant value in both our software and in our business model." About MDS Pharma Services MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process - Early Stage: lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (bioequivalence, phases I-IIa) and bioanalysis; and Late Stage: global clinical development (phases IIb-IV) and central lab. For more information, visit MDS Pharma Services' Web site at http://www.mdsps.com/. MDS Pharma Services is an integral part of MDS Inc. (TSX: MDS; NYSE: MDZ). MDS Inc. has more than 8,800 highly skilled people in 27 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at http://www.mdsinc.com/ or by calling 1-800-MDS-7222, 24 hours a day. About DataLabs DataLabs is an innovative developer of Web-based applications for clinical development that helps the CRO and biopharmaceutical industries accelerate clinical trials with proven software for electronic clinical data management, electronic clinical collaboration, site management, and web based eLearning software. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabs Clinical product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabs Clinical customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations (CROs) are currently realizing time and cost savings using DataLabs Clinical. DataLabs, a Microsoft Certified Partner, is based in Irvine, Calif. with East Coast offices in Pennsylvania. Additional information about DataLabs is available at http://www.datalabs.com/. DATASOURCE: MDS Pharma Services CONTACT: For Investors, Sharon Mathers, (416) 675-6777, ext. 2695, ; For Media, Charlene McGrady, (610) 239-7900, ext. 231,

Copyright